ZA201703579B - Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration - Google Patents

Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration

Info

Publication number
ZA201703579B
ZA201703579B ZA2017/03579A ZA201703579A ZA201703579B ZA 201703579 B ZA201703579 B ZA 201703579B ZA 2017/03579 A ZA2017/03579 A ZA 2017/03579A ZA 201703579 A ZA201703579 A ZA 201703579A ZA 201703579 B ZA201703579 B ZA 201703579B
Authority
ZA
South Africa
Prior art keywords
regeneration
repair
pharmaceutical compositions
aromatic compounds
substituted aromatic
Prior art date
Application number
ZA2017/03579A
Other languages
English (en)
Inventor
Gagnon Lyne
Laurin Pierre
Original Assignee
Prometic Pharma Smt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometic Pharma Smt Ltd filed Critical Prometic Pharma Smt Ltd
Publication of ZA201703579B publication Critical patent/ZA201703579B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/32—Phenylacetic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/52—Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA2017/03579A 2014-11-12 2017-05-24 Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration ZA201703579B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462078704P 2014-11-12 2014-11-12
PCT/CA2015/000572 WO2016074068A1 (en) 2014-11-12 2015-11-12 Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration

Publications (1)

Publication Number Publication Date
ZA201703579B true ZA201703579B (en) 2018-08-29

Family

ID=55953490

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2017/03579A ZA201703579B (en) 2014-11-12 2017-05-24 Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration

Country Status (19)

Country Link
US (3) US10391073B2 (cg-RX-API-DMAC7.html)
EP (1) EP3217968A4 (cg-RX-API-DMAC7.html)
JP (1) JP6720169B2 (cg-RX-API-DMAC7.html)
KR (1) KR20170072352A (cg-RX-API-DMAC7.html)
CN (1) CN107106526B (cg-RX-API-DMAC7.html)
AR (1) AR102634A1 (cg-RX-API-DMAC7.html)
AU (2) AU2015345943B2 (cg-RX-API-DMAC7.html)
BR (1) BR112017009899A2 (cg-RX-API-DMAC7.html)
CA (1) CA2967499C (cg-RX-API-DMAC7.html)
IL (1) IL252221B (cg-RX-API-DMAC7.html)
MX (1) MX381687B (cg-RX-API-DMAC7.html)
MY (1) MY187515A (cg-RX-API-DMAC7.html)
PH (1) PH12017500856A1 (cg-RX-API-DMAC7.html)
RU (1) RU2728782C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201703741TA (cg-RX-API-DMAC7.html)
TW (1) TWI723967B (cg-RX-API-DMAC7.html)
UY (1) UY36399A (cg-RX-API-DMAC7.html)
WO (1) WO2016074068A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201703579B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI742541B (zh) * 2013-03-15 2021-10-11 英商邊緣生物科技有限公司 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
AU2015345943B2 (en) * 2014-11-12 2020-03-19 Liminal Biosciences Limited Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2289417C1 (ru) * 2005-04-15 2006-12-20 Равиль Шамилевич Мирхайдаров Способ биологического омоложения кожи
EP1953222A1 (en) * 2007-01-24 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Improvement of cell growth
EP2427416B1 (en) 2009-05-04 2016-03-09 Prometic Pharma Smt Limited Substituted aromatic compounds and pharmaceutical uses thereof
BRPI1015118A2 (pt) * 2009-05-04 2016-04-12 Prometic Biosciences Inc sais de ácido pentilfenilacético e usos farmacêuticos dos mesmos
ES2351005B1 (es) * 2009-07-10 2011-11-18 Consejo Superior De Investigaciones Científicas (Csic) Uso de anhidrasa carbónica ii para la elaboración de un medicamento.
US20130225683A1 (en) * 2010-10-27 2013-08-29 Prometic Biosciences Inc. Compounds and Pharmaceutical Compositions for Uses in Diabetes
CN105997967B (zh) 2010-10-27 2019-08-23 普罗米蒂克医药Smt有限公司 用于治疗癌症的化合物和组合物
PH12013500763B1 (en) * 2010-10-27 2018-07-04 Prometic Pharma Smt Ltd Phenylketone carboxylate compounds and pharmaceutical uses thereof
JP5388233B2 (ja) * 2011-01-19 2014-01-15 富士ソフト株式会社 再生軟骨の軟骨特性を評価する方法
WO2013021093A1 (es) * 2011-08-10 2013-02-14 Digna Biotech, S.L. Uso de la cardiotofina-1 para el tratamiento de enfermedades renales
TWI689490B (zh) 2013-03-15 2020-04-01 英商邊緣生物科技有限公司 用於治療纖維化之經取代之芳族化合物及相關方法
TWI742541B (zh) 2013-03-15 2021-10-11 英商邊緣生物科技有限公司 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
PL3203999T3 (pl) 2014-10-10 2020-07-27 Liminal Biosciences Limited Podstawione związki aromatyczne i kompozycje farmaceutyczne do zapobiegania i leczenia osteoporozy
SG11201702812PA (en) 2014-10-10 2017-05-30 Prometic Pharma Smt Ltd Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes
AU2015345943B2 (en) * 2014-11-12 2020-03-19 Liminal Biosciences Limited Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration

Also Published As

Publication number Publication date
EP3217968A4 (en) 2018-06-20
TW201618764A (zh) 2016-06-01
PH12017500856A1 (en) 2017-11-06
RU2017120401A (ru) 2018-12-13
CA2967499A1 (en) 2016-05-19
US10391073B2 (en) 2019-08-27
EP3217968A1 (en) 2017-09-20
MY187515A (en) 2021-09-24
TWI723967B (zh) 2021-04-11
WO2016074068A1 (en) 2016-05-19
MX381687B (es) 2025-03-13
UY36399A (es) 2016-06-30
MX2017006281A (es) 2017-08-14
US20170312237A1 (en) 2017-11-02
US20210085626A1 (en) 2021-03-25
AR102634A1 (es) 2017-03-15
RU2728782C2 (ru) 2020-07-31
AU2020204112A1 (en) 2020-07-09
AU2015345943B2 (en) 2020-03-19
BR112017009899A2 (en) 2018-01-16
AU2015345943A1 (en) 2017-06-01
IL252221B (en) 2022-04-01
JP6720169B2 (ja) 2020-07-08
CN107106526A (zh) 2017-08-29
KR20170072352A (ko) 2017-06-26
CA2967499C (en) 2023-01-17
SG11201703741TA (en) 2017-06-29
US20200078324A1 (en) 2020-03-12
JP2017533928A (ja) 2017-11-16
AU2020204112B2 (en) 2021-10-21
RU2017120401A3 (cg-RX-API-DMAC7.html) 2019-06-06
US10869849B2 (en) 2020-12-22
IL252221A0 (en) 2017-07-31
CN107106526B (zh) 2021-05-28

Similar Documents

Publication Publication Date Title
IL268316B (en) Pharmaceutical preparations for combined treatment
SG11201706123XA (en) Pharmaceutical compositions comprising meloxicam
ZA201706007B (en) Pharmaceutical compositions for combination therapy
IL247062A0 (en) Heterocyclic compounds, their preparation and pharmaceutical preparations containing them
GB201409471D0 (en) Pharmaceutical composition
SG11201605366QA (en) Pharmaceutical composition containing pyridylaminoacetic acidcompound
GB201409488D0 (en) Pharmaceutical composition
GB201409485D0 (en) Pharmaceutical composition
ZA201702639B (en) Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
PL3313370T3 (pl) Okulistyczna kompozycja farmaceutyczna
ZA201508726B (en) Pharmaceutical composition
ZA201502073B (en) Pharmaceutical composition
PL3203998T3 (pl) Podstawione związki aromatyczne i kompozycje farmaceutyczne do zapobiegania i leczenia cukrzycy
IL263247A (en) Pharmaceutical preparations containing spinamide
IL252221A0 (en) Transformed aromatic compounds and pharmaceutical preparations for self-repair and tissue reconstruction
SG11201608123VA (en) Pharmaceutical composition for external use
PT3089740T (pt) Composição farmacêutica
SG11201608124XA (en) Pharmaceutical composition for external use
ZA201500995B (en) Low dose pharmaceutical composition
SG10201504332VA (en) Pharmaceutical Composition
HK1238529A1 (en) Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration
SG11201608122PA (en) Pharmaceutical composition for external use
ZA201700064B (en) Pharmaceutical compositions comprising antibacterial agents
SG11201607893TA (en) Hemostatic pharmaceutical composition
HRP20220610T8 (hr) Farmaceutski pripravci koji sadrže meloksikam